Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Filipa Lynce, M.D.

Concepts (190)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Filipa Lynce's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Filipa Lynce has written about over time.
Ventricular Dysfunction, Left, 2 publications between 2017 and 2019, average publication date March 2018. Antineoplastic Agents, 9 publications between 2014 and 2024, average publication date January 2020. Breast Neoplasms, 34 publications between 2012 and 2024, average publication date April 2020. BRCA1 Protein, 9 publications between 2016 and 2024, average publication date November 2020. BRCA2 Protein, 9 publications between 2016 and 2024, average publication date November 2020. Ovarian Neoplasms, 4 publications between 2016 and 2023, average publication date November 2020. Platinum, 1 publications between 2021 and 2021, average publication date March 2021. Receptor, ErbB-2, 10 publications between 2017 and 2024, average publication date May 2021. Antineoplastic Combined Chemotherapy Protocols, 11 publications between 2012 and 2024, average publication date June 2021. Nitriles, 2 publications between 2021 and 2024, average publication date August 2022. Pyrazoles, 2 publications between 2021 and 2024, average publication date August 2022. Paclitaxel, 3 publications between 2021 and 2024, average publication date September 2022. Neoadjuvant Therapy, 12 publications between 2020 and 2024, average publication date December 2022. Inflammatory Breast Neoplasms, 8 publications between 2022 and 2024, average publication date July 2023.

To see the data from this visualization as text, click here.
Lynce's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (190)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.